THIS TASK ORDER (TO) IS TO PROVIDE DOSAGE FORM DEVELOPMENT, MANUFACTURE AND STABILITY STUDIES OF ORC-13661 FOR PHASE II CLINICAL TRIAL

NIH RePORTER · NIH · N01 · $180,000 · view on reporter.nih.gov ↗

Abstract

Dosage Form Development, Manufacture and Stability Studies of ORC-13661 for Phase II Clinical Trial

Key facts

NIH application ID: 11221085
Project number: 271201700020I-P00001-759502200001-1
Recipient: IRISYS, INC.
Principal Investigator: TIM BOURQUE
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $180,000
Award type: —
Project period: 2022-09-28 → 2027-07-31